South San Francisco, CA March 20, 2023 Press Release New Four-Year Data for Genentech’s Evrysdi Reinforce Long-Term Efficacy and Safety Profile in Some of the Most Severely Affected People With Types 2 and 3 Spinal Muscular Atrophy (SMA) Data…
Tag: Spinal muscular atrophy
Genentech Presents Data from Studies in Spinal Muscular Atrophy at the 2019 AAN Annual Meeting
South San Francisco, CA May 7, 2019 Genentech Press Release Genentech Presents Data from the Risdiplam Pivotal FIREFISH and SUNFISH Studies in Spinal Muscular Atrophy at the 2019 AAN Annual Meeting In the dose-finding Part 1 of FIREFISH, infants with…
Genentech to Present New Data at AAN Highlighting Extensive Research for Ocrevus and Expanding Neuroscience Pipeline
South San Francisco, CA April 16, 2018 Genentech Press Release Breadth of data will reinforce efficacy and safety of OCREVUS in relapsing and primary progressive multiple sclerosis and demonstrate its benefits in slowing disability progression, including new cognitive and biomarker…